MYC
Asset
Dissolves oncogenic transcriptional MYC condensates, inhibiting MYC’s oncogenic functions.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- MYC
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Solid tumor
Preclinical, dewpointx.com, 10 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors5
Every asset’s record: target, stage, trials and the evidence behind it.